Cook Meredith 4

What Happened

• Meredith Cook, Senior Vice President, General Counsel & Secretary of ANI Pharmaceuticals (ANIP), disposed of 3,813 shares of ANIP stock in mid-February 2026 for a total of approximately $293,681. Transactions comprised shares withheld to cover taxes on vested restricted stock (cashless/withholding) and a separate open-market sale under a Rule 10b5-1 plan. These were sales/withholdings (routine disposition), not purchases.

Key Details

• Total disposed: 3,813 shares for ~$293,681
  • Feb 12, 2026: 1,534 shares withheld at $76.70 — $117,658 (tax withholding; footnote F1)
  • Feb 13, 2026: 500 shares sold at $76.80 — $38,400 (open-market sale under a Rule 10b5-1 plan; footnote F2)
  • Feb 14, 2026: 1,779 shares withheld at $77.36 — $137,623 (tax withholding; footnote F3)
• Footnotes:
  • F1: Withheld shares relate to vesting of 4,243 restricted shares (grant previously reported 2/18/2025).
  • F2: Feb 13 sale executed under a 10b5-1 trading plan adopted Sept 15, 2025.
  • F3: Withheld shares relate to vesting of 3,691 restricted shares (grant previously reported 2/16/2024).
• Shares owned after the transactions: Not disclosed in the provided filing.
• Filing timeliness: Report lists the period of report as Feb 12, 2026 and was filed on Feb 17, 2026 — one business day later than the standard two-business-day Form 4 deadline.

Context

• The two withholding transactions are cashless tax-withholding in connection with restricted stock vesting (common and administrative). The 500-share sale was an open-market trade executed under a pre-established Rule 10b5-1 plan (automated plan to sell at set times/conditions). These actions are disposals and generally viewed as routine; they do not by themselves indicate insider confidence or lack thereof.